No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

Medneuvit 600 | Pharmacountry

Products
Finished Dosage Forms
Injectables & Parenterals
Large Volume Parenterals (LVP)/IV Infusions

Medneuvit 600

CT

Công ty TNHH Sản xuất Dược phẩm Medlac Pharma Italy

Manufacturer · Finished Dosage FormsViet Nam

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Injectables & Parenterals / Large Volume Parenterals (LVP)/IV Infusions

Trade Type

Sell

Product Name

Medneuvit 600

Details

Substance

Manufacturer(s)

Công ty TNHH Sản xuất Dược phẩm Medlac Pharma Italy - Viet Nam

Registered Market

Viet Nam

Specifications

Dosage Form: Solution concentrate for reconstitution as injection/infusion
Packaging: Box 5 ampoule x 20 mL, box 10 ampoule x 20 mL
Strength: 600mg/20ml
Standards: In-house standard
Shelf Life: 24 month

Documents

Drug Marketing Authorization Number

Document No.: 893110114525

Issue Date: Mar 13, 2025

Expiry Date: Mar 13, 2030

Note: 124/QĐ-QLD | 216